Mandate

Vinge has advised ABG Sundal Collier and Carnegie in connection with Permascand’s listing on Nasdaq First North Premier Growth Market

June 04, 2021

Vinge has advised ABG Sundal Collier and Carnegie in connection with Permascand’s listing on Nasdaq First North Premier Growth Market. Trading on Nasdaq First North Premier Growth Market commenced on 4 June 2021.

The price per share in the offering was SEK 34 per share, corresponding to a total value of approximately SEK 2,017 million for all outstanding shares in the Permascand following the completion of the offering. The Offering comprised 14,860,627 shares, corresponding to approximately 25.1 percent of the total number of shares in the company following the completion of the offering, of which 8,823,529 shares were newly issued shares and 6,037,098 shares were existing shares sold by Norvestor VI, L.P. and a few other shareholders

Permascand is an independent technology-driven manufacturer of electrochemical solutions based on proprietary catalytic coatings for cleantech applications. With a customer-centric focus, Permascand has supplied electrodes, electrochemical cells, and aftermarket services to a variety of sectors for the past 50 years.

Vinge’s team consisted of Dain Hård Nevonen, Linnéa Sellström and Eléonore Friberg.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025